Literature DB >> 1402672

Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.

N Arima1, M Kamio, K Imada, T Hori, T Hattori, M Tsudo, M Okuma, T Uchiyama.   

Abstract

Functional studies of the interleukin 2 receptor (IL-2R) of two (ED515-D and Kit225) IL-2-dependent and three (ED515-I, 3T3-alpha beta 11, and Hut102) IL-2-independent cell lines were done. All of these cell lines appeared to express high as well as low affinity IL-2R. However, ED515-I and 3T3-alpha beta 11, which expressed the IL-2R beta chain, did not bind IL-2 at all when IL-2 binding to their IL-2R alpha chain was blocked with anti-Tac monoclonal antibody, whereas the intermediate affinity binding in ED515-D, Kit225, and Hut102 cells remained. We tentatively called the high affinity IL-2R of the former cells pseudo-high affinity IL-2R. The dissociation constant of pseudo-high affinity IL-2R was higher than that of ordinary high affinity IL-2R. Internalization of cell-bound 125I-IL-2 into ED515-I and 3T3-alpha beta 11 cells was less efficient than that into ED515-D cells. The addition of IL-2 neither promoted cell growth nor upregulated IL-2R alpha chain expression in ED515-I and 3T3-alpha beta 11 cells. Furthermore, tyrosine phosphorylation of the cellular proteins (p120, p98, p96, p54, and p38) was induced or enhanced in response to the addition of IL-2 in ED515-D and Kit225 cells, but not in the cell lines expressing pseudo-high affinity IL-2R. Finally, 125I-IL-2 crosslinking followed by SDS-PAGE analysis showed an 80-kD band corresponding to p65 + IL-2, in addition to bands corresponding to IL-2R alpha and beta chain + IL-2 in cells bearing ordinary high affinity IL-2R but not in cells with pseudo-high affinity IL-2R. Taken together, we consider that another protein whose molecular mass is approximately 65 kD is functionally important in IL-2 binding and subsequent signal transduction and may be the third component of IL-2R.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402672      PMCID: PMC2119428          DOI: 10.1084/jem.176.5.1265

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Role of alpha chain-IL-2 complex in the formation of the ternary complex of IL-2 and high-affinity IL-2 receptor.

Authors:  M Kamio; T Uchiyama; N Arima; K Itoh; T Ishikawa; T Hori; H Uchino
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  Biochemical evidence for a third chain of the interleukin-2 receptor.

Authors:  Y Saito; H Tada; H Sabe; T Honjo
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

3.  An associated molecule, p64, with high-affinity interleukin 2 receptor.

Authors:  T Takeshita; H Asao; J Suzuki; K Sugamura
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

4.  An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex.

Authors:  T Takeshita; K Ohtani; H Asao; S Kumaki; M Nakamura; K Sugamura
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

5.  Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells.

Authors:  I Dibirdik; M C Langlie; J A Ledbetter; L Tuel-Ahlgren; V Obuz; K G Waddick; K Gajl-Peczalska; G L Schieven; F M Uckun
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

6.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

7.  The IL-2 receptor alpha-chain alters the binding of IL-2 to the beta-chain.

Authors:  N Arima; M Kamio; M Okuma; G Ju; T Uchiyama
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

8.  A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor.

Authors:  M R Fung; R M Scearce; J A Hoffman; N J Peffer; S R Hammes; J B Hosking; R Schmandt; W A Kuziel; B F Haynes; G B Mills
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

9.  Putative gamma-subunit of the IL-2 receptor is detected in low, intermediate, and high affinity IL-2 receptor-bearing cells.

Authors:  O R Colamonici; L M Neckers; A Rosolen
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

10.  Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.

Authors:  S D Voss; R J Robb; G Weil-Hillman; J A Hank; K Sugamura; M Tsudo; P M Sondel
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  23 in total

1.  Protein engineering: Tighter ties that bind.

Authors:  Eric T Boder
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

2.  Absence of γ-Chain in Keratinocytes Alters Chemokine Secretion, Resulting in Reduced Immune Cell Recruitment.

Authors:  Karolin Nowak; Daniela Linzner; Adrian J Thrasher; Paul F Lambert; Wei-Li Di; Siobhan O Burns
Journal:  J Invest Dermatol       Date:  2017-06-17       Impact factor: 8.551

Review 3.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

Review 4.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

5.  Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.

Authors:  J W Gratama; R J Bruin; C H Lamers; R Oosterom; E Braakman; G Stoter; R L Bolhuis
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

6.  Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.

Authors:  Naoki Mori; Takehiro Matsuda; Masayuki Tadano; Takao Kinjo; Yasuaki Yamada; Kunihiro Tsukasaki; Shuichi Ikeda; Yoshihiro Yamasaki; Yuetsu Tanaka; Takao Ohta; Teruo Iwamasa; Masao Tomonaga; Naoki Yamamoto
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.

Authors:  M A Wasik; N Sioutos; M Tuttle; J R Butmarc; W D Kaplan; M E Kadin
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

Review 8.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

9.  Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes.

Authors:  Nerea Osinalde; Jone Mitxelena; Virginia Sánchez-Quiles; Vyacheslav Akimov; Kerman Aloria; Jesus M Arizmendi; Ana M Zubiaga; Blagoy Blagoev; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2016-04-11       Impact factor: 5.911

10.  A membrane-proximal region of the interleukin-2 receptor gamma c chain sufficient for Jak kinase activation and induction of proliferation in T cells.

Authors:  B H Nelson; J D Lord; P D Greenberg
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.